Parliament makes the Critical Medicines Act meaningful but significant risks to future access persist

20 January 2026

Steffen Saltofte (Zentiva) named President of Medicines for Europe

7 January 2026

The EU Biosimilar industry, which is central to competitiveness, needs Ambitious, Coherent, & Competition-Driven Biotech Policies

17 December 2025

Parliament SANT Committee vote takes the high road on medicines security in Critical Medicines Act Report

17 December 2025

The Safe Hearts Plan should improve access to affordable innovation and better treatment for all patients

17 December 2025

Pharma legislation deal important for the future EU pharmaceutical industry but most importantly for access to medicine

12 December 2025

Environment omnibus and impact study fail to address huge flaws in Urban waste water treatment directive

12 December 2025

Europe’s antibiotic shortages are a policy failure requiring urgent reform

8 December 2025

Europe faces chronic antibiotic shortages driven by rising production costs […]

Biosimilars 2025: A Turning Point for equitable access and EU competitiveness

4 December 2025

European study shows falling prices, rising costs and shortages – findings released during World AMR Awareness Week

19 November 2025